Overview

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
Phase:
Phase 2
Details
Lead Sponsor:
ThromboGenics
Treatments:
Plasminogen